# ESOMEPRAZOLE MAGNESIUM
> **ANDA213859** · Abbreviated New Drug Application (Generic) · Sponsor: GUANGZHOU NOVAKEN · Approved 2020-11-18
## Drug
- **FDA Application Number:** ANDA213859
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESOMEPRAZOLE MAGNESIUM
- **Generic name:** ESOMEPRAZOLE MAGNESIUM
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM
- **Dosage form:** CAPSULE, DELAYED REL PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GUANGZHOU NOVAKEN
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2020-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213859)
---
*AI Analytics · CC0 1.0*